FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 3210323 · Received July 8, 2013

Report

Report Number
2124215-2013-09229
Event Type
Malfunction
Date Received
July 8, 2013
Date of Event
April 19, 2013
Report Date
April 19, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MD
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS DEVICE WAS UNABLE TO BE INTERROGATED. TWO DIFFERENT PROGRAMMERS WERE USED AND NO SUCCESS. THIS DEVICE REMAINS IMPLANTED AT THIS TIME WITH NO PLANS FOR INTERVENTION. TO DATE, NO ADVERSE PATIENT EFFECTS HAVE BEEN REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
310385 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E102

Patients

Seq Age Sex Outcome Treatment
1 53 YR 0147| E102